Pitching Your Biotech To Investors

Telling your story in a way that drives investment results

As Allan Shaw put it in the kickoff episode of The Business Of Biotech podcast, and despite the COVID-19 pandemic’s impact on the economy in general, there has never been so much money available to emerging biopharmas, and there have never been so many people with their hands out. Early-stage biopharmas find themselves in an increasingly crowded field of companies seeking capital, and the noisier the crowd gets, the harder it is to differentiate your science, your people, and your value proposition.

Unless you’re extremely lucky or the spouse or offspring of a billionaire, successfully producing investor dollars from the story of your science, people, and value proposition is going to require a pitch deck and tireless energy to present it. Multi-time biotech founder Leslie Williams has been down this road more than once, and she’s got plenty of candid advice on building a pitch deck and preparing for the pitching process. Williams shared that advice on The Business Of Biotech podcast, produced by BioProcess Online and supported by Cytiva.